0,889  0,004  Antihypercholesterolemic
0,881  0,001  Aldose reductase substrate
0,879  0,003  Genotoxic
0,877  0,003  UGT1A9 substrate
0,868  0,003  Cholesterol antagonist
0,869  0,010  Alpha-glucosidase inhibitor
0,841  0,003  Antihypoxic
0,839  0,005  Chemoprotective
0,836  0,003  NOS3 expression inhibitor
0,837  0,007  Teratogen
0,834  0,004  Antioxidant
0,838  0,011  Antiinflammatory
0,831  0,007  Embryotoxic
0,824  0,001  Amylase inhibitor
0,824  0,008  Caspase 9 stimulant
0,815  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,814  0,005  Mutagenic
0,803  0,006  Cyclophilin D inhibitor
0,803  0,006  Antidiabetic
0,795  0,004  Free radical scavenger
0,796  0,013  Transcription factor NF kappa B inhibitor
0,780  0,005  Sensitization
0,764  0,003  UGT1A1 substrate
0,778  0,019  Apoptosis agonist
0,749  0,004  Angiogenesis stimulant
0,743  0,005  Cardioprotectant
0,748  0,010  CYP2C9 substrate
0,737  0,006  Antithrombotic
0,734  0,008  Chemopreventive
0,722  0,004  Antimutagenic
0,722  0,010  Carcinogenic
0,695  0,005  Antipyretic
0,695  0,010  Respiratory analeptic
0,691  0,008  Cytostatic
0,686  0,004  NOS3 expression enhancer
0,684  0,005  UDP-glucuronosyltransferase substrate
0,680  0,005  DNA damaging
0,670  0,004  Monophenol monooxygenase inhibitor
0,672  0,011  Antibacterial
0,659  0,010  Analeptic
0,642  0,006  Hypoglycemic
0,641  0,007  UGT1A6 substrate
0,644  0,011  Vasodilator, peripheral
0,638  0,006  Apoptosis antagonist
0,635  0,005  Vascular (periferal) disease treatment
0,631  0,003  Xanthine oxidase inhibitor
0,633  0,009  Hepatic disorders treatment
0,629  0,005  Skin whitener
0,622  0,004  Hepatoprotectant
0,613  0,002  Cyclooxygenase 3 inhibitor
0,613  0,002  Antineoplastic, alkylator
0,608  0,002  NADH dehydrogenase inhibitor
0,619  0,013  Radioprotector
0,603  0,003  UGT2B4 substrate
0,609  0,010  Antiparasitic
0,605  0,009  Nitric oxide antagonist
0,588  0,001  UDP-glucose 4-epimerase inhibitor
0,602  0,016  Immunostimulant
0,586  0,004  Melanin inhibitor
0,590  0,013  Proliferative diseases treatment
0,584  0,008  DNA synthesis inhibitor
0,580  0,005  Interleukin agonist
0,576  0,007  RNA-directed DNA polymerase inhibitor
0,584  0,015  Immunosuppressant
0,572  0,003  Antifungal enhancer
0,569  0,003  Protein kinase stimulant
0,560  0,003  Hexokinase inhibitor
0,572  0,015  Antipruritic, allergic
0,570  0,015  Cytotoxic
0,569  0,015  Immunomodulator
0,580  0,028  TNF expression inhibitor
0,562  0,029  Antileukemic
0,529  0,002  Mannose-6-phosphate isomerase inhibitor
0,529  0,006  Anesthetic general
0,529  0,009  Antihypertriglyceridemic
0,532  0,017  AR expression inhibitor
0,517  0,005  Lipid peroxidase inhibitor
0,512  0,005  Alkylator
0,509  0,004  Mediator release inhibitor
0,515  0,013  Tumour necrosis factor alpha release inhibitor
0,519  0,018  Caspase 3 stimulant
0,516  0,017  NOS2 expression inhibitor
0,512  0,015  Antiamyloidogenic
0,499  0,005  Antiviral (Influenza)
0,507  0,015  Vasodilator, coronary
0,510  0,019  Antiischemic
0,503  0,011  ICAM1 expression inhibitor
0,500  0,012  Vasodilator
0,507  0,022  Spasmolytic
0,487  0,003  Selectin antagonist
0,487  0,010  Interleukin 2 agonist
0,479  0,003  Antiviral (Influenza B)
0,481  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,483  0,007  Non-steroidal antiinflammatory agent
0,487  0,011  Myocardial infarction treatment
0,477  0,003  Triose-phosphate isomerase inhibitor
0,488  0,014  Antineoplastic (lymphoma)
0,487  0,024  Antifungal
0,492  0,030  Stroke treatment
0,468  0,007  Antihypotensive
0,471  0,017  Amyloid beta aggregation inhibitor
0,462  0,014  Antineoplastic (liver cancer)
0,458  0,010  Septic shock treatment
0,461  0,014  Antineoplastic (osteosarcoma)
0,467  0,024  Antineoplastic (brain cancer)
0,444  0,004  Antihemorrhagic
0,448  0,010  Antiviral (Herpes)
0,445  0,012  Antineoplastic (sarcoma)
0,441  0,008  Platelet adhesion inhibitor
0,465  0,033  Ulceration
0,450  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,426  0,006  Acaricide
0,431  0,019  Radiosensitizer
0,417  0,008  Antipruritic, non-allergic
0,444  0,035  CYP2C19 substrate
0,411  0,003  Carbonic anhydrase XIV inhibitor
0,412  0,005  Expectorant
0,429  0,026  Antidiabetic (type 2)
0,450  0,050  Histamine release inhibitor
0,408  0,010  Topoisomerase II inhibitor
0,400  0,006  DNA polymerase I inhibitor
0,396  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,391  0,001  Alpha-mannosidase inhibitor
0,389  0,005  Carcinogenic, group 1
0,388  0,009  Hemostatic
0,380  0,002  Mannosidase inhibitor
0,387  0,008  Interleukin 6 antagonist
0,375  0,006  Topoisomerase I inhibitor
0,377  0,009  Antiviral (Influenza A)
0,369  0,003  Phosphorylase inhibitor
0,376  0,012  VCAM1 expression inhibitor
0,370  0,007  Glutathione S-transferase substrate
0,374  0,013  DNA methylase inhibitor
0,361  0,010  Peptidyltransferase inhibitor
0,363  0,013  Interferon gamma antagonist
0,370  0,020  Antihelmintic
0,370  0,021  Cyclic AMP phosphodiesterase inhibitor
0,349  0,004  ATPase inhibitor
0,385  0,043  Lipoprotein disorders treatment
0,380  0,040  Antineoplastic (cervical cancer)
0,361  0,024  Wound healing agent
0,364  0,028  Antineoplastic (endocrine cancer)
0,335  0,004  Phosphofructokinase-1 inhibitor
0,394  0,066  Antineoplastic (lung cancer)
0,333  0,008  Cell wall synthesis inhibitor
0,335  0,011  Neurotrophic factor enhancer
0,339  0,016  Carcinogenic, group 3
0,327  0,005  Carbonic anhydrase XIII inhibitor
0,331  0,009  Sulfotransferase substrate
0,350  0,029  Antiulcerative
0,371  0,051  Antineoplastic (ovarian cancer)
0,366  0,047  Antineoplastic (pancreatic cancer)
0,350  0,034  Antineoplastic (small cell lung cancer)
0,382  0,068  CYP3A4 substrate
0,395  0,081  Antineoplastic (breast cancer)
0,331  0,019  Thrombolytic
0,318  0,008  Nitric-oxide synthase stimulant
0,345  0,037  Antidiabetic symptomatic
0,367  0,061  Antineoplastic (colorectal cancer)
0,316  0,010  Aldehyde dehydrogenase inhibitor
0,397  0,094  Antiarthritic
0,332  0,034  Antineoplastic (lymphocytic leukemia)
0,353  0,056  Antipsoriatic
0,300  0,004  Transcription factor NF kappa B stimulant
0,314  0,022  DNA methyltransferase I inhibitor
0,297  0,006  Carbonic anhydrase VI inhibitor
0,295  0,004  Histone deacetylase SIRT1 stimulant
0,295  0,004  Histone deacetylase stimulant
0,313  0,024  UGT2B7 substrate
0,302  0,013  Adenylate cyclase inhibitor
0,353  0,065  Prostate cancer treatment
0,306  0,018  Phospholipase C inhibitor
0,296  0,014  Antidiarrheal
0,287  0,007  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,333  0,060  5 Hydroxytryptamine release stimulant
0,276  0,004  Heat shock protein 70 antagonist
0,291  0,020  Antihelmintic (Nematodes)
0,279  0,012  Cystathionine beta-synthase inhibitor
0,274  0,009  Antibacterial (Helicobacter pylori)
0,298  0,034  Antiviral (HIV)
0,269  0,008  Dementia treatment
0,264  0,005  Carcinogenic, group 2A
0,296  0,037  Antineoplastic enhancer
0,306  0,047  Hypolipemic
0,266  0,008  Vascular dementia treatment
0,309  0,051  Antiprotozoal (Leishmania)
0,261  0,004  Thioredoxin inhibitor
0,274  0,019  Antidote
0,293  0,039  Peroxidase inhibitor
0,259  0,008  Beta glucuronidase inhibitor
0,256  0,006  Mucolytic
0,248  0,004  Phosphodiesterase 6D inhibitor
0,252  0,009  Antispirochetal
0,250  0,007  HIV-1 integrase (3'-Processing) inhibitor
0,251  0,009  Toll-Like receptor 2 antagonist
0,251  0,009  Antifungal (Cryptococcus)
0,306  0,068  Antineoplastic (melanoma)
0,264  0,027  Restenosis treatment
0,295  0,059  Antineoplastic (glioma)
0,242  0,007  AMP-activated protein kinase stimulant
0,244  0,010  Choleretic
0,248  0,014  Antineoplastic antibiotic
0,306  0,074  Antineoplastic (colon cancer)
0,259  0,027  Antineoplastic (gastric cancer)
0,288  0,057  Antineoplastic (renal cancer)
0,240  0,010  Antirickettsial
0,235  0,006  DNA repair enzyme inhibitor
0,254  0,026  UGT2B15 substrate
0,232  0,004  Toll-Like receptor 4 antagonist
0,234  0,008  Photosensitizer
0,232  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,236  0,011  Topoisomerase II alpha inhibitor
0,344  0,120  5 Hydroxytryptamine release inhibitor
0,253  0,031  Antiviral (Hepatitis)
0,222  0,001  Glucose-6-phosphate isomerase inhibitor
0,249  0,030  Antineoplastic (squamous cell carcinoma)
0,325  0,107  Antiprotozoal
0,222  0,004  Neuraminidase (influenza) inhibitor
0,237  0,020  Antihyperlipoproteinemic
0,229  0,019  Gout treatment
0,223  0,013  Carbonic anhydrase III inhibitor
0,222  0,012  Adenylate kinase inhibitor
0,218  0,011  Antibiotic
0,335  0,129  Calcium channel L-type activator
0,236  0,030  Muscular dystrophy treatment
0,223  0,019  Cell adhesion inhibitor
0,266  0,065  Platelet antagonist
0,285  0,086  Antimycobacterial
0,232  0,034  Antiacne
0,207  0,012  Uric acid excretion stimulant
0,293  0,099  Calcium channel activator
0,220  0,027  Insulin secretagoues
0,238  0,047  Myocardial ischemia treatment
0,192  0,003  Squalene epoxidase inhibitor
0,192  0,004  Ca2+-transporting ATPase inhibitor
0,201  0,016  Beta amyloid protein antagonist
0,198  0,016  UGT2B1 substrate
0,263  0,082  GST M1-1 substrate
0,206  0,027  Antiviral (Hepatitis B)
0,212  0,033  Skin irritative effect
0,221  0,043  Diabetic nephropathy treatment
0,227  0,049  Insulin sensitizer
0,215  0,038  Antiviral (Ebola)
0,200  0,024  Chelator
0,240  0,066  Antineoplastic (glioblastoma multiforme)
0,254  0,080  Transcription factor STAT3 inhibitor
0,256  0,087  Antiosteoporotic
0,184  0,017  Vanilloid 1 agonist
0,205  0,038  Neuropathy treatment
0,186  0,021  Adenylate cyclase stimulant
0,171  0,008  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,189  0,028  Antitussive
0,229  0,068  Pyruvate kinase inhibitor
0,174  0,014  Actinic keratosis treatment
0,292  0,133  CYP2C19 inhibitor
0,165  0,006  Antiviral (Dengue virus)
0,173  0,017  Chronic obstructive bronchitis treatment
0,160  0,005  Neuraminidase inhibitor
0,198  0,043  Antiviral (Hepatitis C)
0,165  0,011  Carbonic anhydrase XII inhibitor
0,179  0,026  Microtubule formation inhibitor
0,170  0,017  Sphingomyelinase inhibitor
0,256  0,104  CTGF expression inhibitor
0,176  0,024  Anticataract
0,180  0,030  Interleukin 4 antagonist
0,156  0,006  Antibiotic Glycopeptide-like
0,153  0,004  Antimycoplasmal
0,258  0,109  Bone diseases treatment
0,177  0,031  Retinoprotector
0,204  0,061  P-glycoprotein inhibitor
0,175  0,034  Cholesterol synthesis inhibitor
0,171  0,030  Antineoplastic antimetabolite
0,151  0,010  Aldose reductase inhibitor
0,182  0,042  Antidiabetic (type 1)
0,177  0,038  Psychosexual dysfunction treatment
0,313  0,175  Antineoplastic (solid tumors)
0,183  0,046  Anesthetic
0,162  0,025  Protein kinase C gamma inhibitor
0,143  0,007  Na+ K+ transporting ATPase inhibitor
0,263  0,127  Antiprotozoal (Plasmodium)
0,240  0,104  Antineoplastic (multiple myeloma)
0,142  0,009  Glycine receptor antagonist
0,157  0,025  Aldehyde dehydrogenase substrate
0,141  0,010  ATPase (Vacuolar H+) inhibitor
0,183  0,054  Protein-tyrosine phosphatase inhibitor
0,138  0,010  GABA aminotransferase inhibitor
0,141  0,014  CDC25A inhibitor
0,181  0,054  UGT2B10 substrate
0,130  0,003  Adenine nucleotide translocase inhibitor
0,148  0,022  Antifungal (Pneumocystis)
0,134  0,009  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,131  0,010  Protein kinase C eta inhibitor
0,124  0,002  Sodium/glucose cotransporter inhibitor
0,120  0,002  Sodium/glucose cotransporter 2 inhibitor
0,129  0,013  Antimetabolite
0,285  0,170  DNA directed DNA polymerase inhibitor
0,153  0,039  Growth stimulant
0,155  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,172  0,062  Arachidonic acid antagonist
0,209  0,100  Antineoplastic (non-small cell lung cancer)
0,163  0,055  CF transmembrane conductance regulator agonist
0,249  0,143  GST A substrate
0,187  0,082  Abortion inducer
0,109  0,004  Adenosine deaminase inhibitor
0,226  0,121  CYP2D6 substrate
0,165  0,063  UGT2B9 substrate
0,158  0,057  Hearing loss treatment
0,110  0,010  Protein kinase C beta inhibitor
0,121  0,022  Glutamate dehydrogenase inhibitor
0,120  0,022  Glutamate release inhibitor
0,144  0,045  DNA intercalator
0,147  0,050  Antihelmintic (Trematoda)
0,115  0,019  Interferon agonist
0,107  0,012  Protein 50S ribosomal subunit inhibitor
0,152  0,058  Renal failure treatment
0,157  0,065  Hair growth stimulant
0,107  0,015  Purinergic P2X1 antagonist
0,189  0,097  Antialcoholic
0,123  0,033  Protein kinase A inhibitor
0,107  0,017  Biliverdin reductase inhibitor
0,208  0,119  Huntington's disease treatment
0,162  0,074  UGT1A3 substrate
0,097  0,010  Nitric oxide donor
0,105  0,019  Carbonic anhydrase IX inhibitor
0,090  0,004  Antibiotic Aminoglycoside-like
0,093  0,007  Glucose-6-phosphate translocase inhibitor
0,147  0,062  Bone formation stimulant
0,087  0,003  Sodium/glucose cotransporter 1 inhibitor
0,226  0,142  Angiogenesis inhibitor
0,097  0,014  Interferon inducer
0,144  0,060  Cyclooxygenase 1 inhibitor
0,218  0,135  Metabolic disease treatment
0,118  0,036  UGT2B11 substrate
0,085  0,003  Uridine phosphorylase inhibitor
0,111  0,031  Antiviral (Trachoma)
0,097  0,017  Antitreponemal
0,117  0,037  Alcohol dehydrogenase inhibitor
0,099  0,020  Phosphodiesterase VI inhibitor
0,153  0,075  Diuretic
0,104  0,026  Carbonic anhydrase inhibitor
0,143  0,065  Neurotrophic factor
0,110  0,034  Ornithine decarboxylase inhibitor
0,213  0,137  CYP1A2 substrate
0,206  0,130  Transcription factor STAT inhibitor
0,082  0,006  Heparanase inhibitor
0,137  0,061  Antiseptic
0,097  0,022  Carbamoyl phosphate synthetase inhibitor
0,152  0,078  Eye irritation, high
0,228  0,154  FMO1 substrate
0,127  0,054  Alcohol dehydrogenase substrate
0,268  0,197  Alzheimer's disease treatment
0,161  0,091  Lipocortins synthesis antagonist
0,162  0,092  Succinate dehydrogenase inhibitor
0,152  0,083  Uterine stimulant
0,074  0,006  Cytokine production stimulant
0,143  0,075  Antiprotozoal (Coccidial)
0,090  0,022  Argininosuccinate synthase inhibitor
0,142  0,075  Antineoplastic (carcinoma)
0,070  0,004  Cholesterol absorption inhibitor
0,141  0,075  SULT1A3 substrate
0,070  0,005  Protein 30S ribosomal subunit inhibitor
0,128  0,064  Gastritis treatment
0,091  0,027  Glycine receptor agonist
0,068  0,006  Guanylate cyclase inhibitor
0,113  0,051  Antischistosomal
0,090  0,031  HIV-1 integrase inhibitor
0,061  0,002  Vanilloid 2 agonist
0,109  0,051  Anabolic
0,081  0,024  Xanthine dehydrogenase inhibitor
0,147  0,090  Cystic fibrosis treatment
0,095  0,039  Vanilloid agonist
0,113  0,058  Carcinogenic, group 2B
0,073  0,019  Lipocortins synthesis agonist
0,095  0,042  Glutathione S-transferase inhibitor
0,088  0,036  Narcotic antagonist
0,075  0,024  Acyl-CoA dehydrogenase inhibitor
0,076  0,025  Transcription factor AP-1 inhibitor
0,110  0,059  DOPA decarboxylase inhibitor
0,065  0,014  Equilibrative nucleoside transport protein inhibitor
0,100  0,050  Protein kinase C zeta inhibitor
0,067  0,017  Prolyl endopeptidase inhibitor
0,076  0,026  Carbonic anhydrase I inhibitor
0,059  0,011  Arginase inhibitor
0,072  0,024  Fatty acid synthase inhibitor
0,099  0,052  Antiviral (Rhinovirus)
0,164  0,118  Pneumotoxic
0,074  0,028  Carbonic anhydrase II inhibitor
0,071  0,026  Postmenopausal disorders treatment
0,076  0,032  CDC25B inhibitor
0,073  0,029  Antiviral (Parainfluenza)
0,123  0,079  NADPH oxidase inhibitor
0,141  0,099  Mcl-1 antagonist
0,057  0,015  Neuraminidase (Influenza A) inhibitor
0,104  0,062  Antiviral (Poxvirus)
0,083  0,042  Glutamate decarboxylase inhibitor
0,123  0,083  Alkaline phosphatase inhibitor
0,069  0,029  Maillard reaction inhibitor
0,058  0,021  Carbonic anhydrase VII inhibitor
0,080  0,043  Adenosine A3 receptor antagonist
0,059  0,023  Topoisomerase II beta inhibitor
0,041  0,004  Ileal bile acid transport inhibitor
0,082  0,046  Keratolytic
0,120  0,086  Antineoplastic (uterine cancer)
0,108  0,075  TRPA1 agonist
0,072  0,040  Gaucher disease treatment
0,179  0,147  Antituberculosic
0,046  0,015  Phosphoglycerate kinase inhibitor
0,084  0,053  Thioredoxin reductase inhibitor
0,094  0,064  Interleukin 12 antagonist
0,175  0,145  Cardiotonic
0,094  0,064  Bile acid receptor antagonist
0,033  0,003  Telomerase stimulant
0,036  0,006  Toll-Like receptor 4 agonist
0,035  0,006  GRP78 expression inhibitor
0,076  0,047  Lipase inhibitor
0,041  0,014  Tubulin agonist
0,050  0,023  Toll-Like receptor 2 agonist
0,053  0,027  Antiviral (Herpesvirus 3, Human)
0,047  0,021  Thymidine kinase inhibitor
0,151  0,125  Osteoarthritis treatment
0,034  0,008  1,3-Beta-glucan synthase inhibitor
0,071  0,045  Anticholelithogenic
0,073  0,048  Histidine decarboxylase inhibitor
0,051  0,027  Microtubule stabilization
0,078  0,054  Arylamine N-Acetyltransferase substrate
0,192  0,168  5 Hydroxytryptamine uptake stimulant
0,076  0,054  NAD(P)H dehydrogenase (quinone) inhibitor
0,026  0,005  Antibiotic Anthracycline-like
0,040  0,019  Fumarate hydratase inhibitor
0,034  0,014  Elastase 3B inhibitor
0,034  0,014  Elastase 2B inhibitor
0,034  0,014  Elastase 3A inhibitor
0,056  0,037  Glucosylceramidase inhibitor
0,035  0,018  Protein kinase C beta I inhibitor
0,029  0,012  Adenosine A1 receptor agonist
0,035  0,019  Catechol O-methyltransferase inhibitor
0,185  0,171  Gastrin inhibitor
0,025  0,012  Isoleucine-tRNA ligase inhibitor
0,049  0,036  Factor III inhibitor
0,032  0,021  Caspase 2 inhibitor
0,199  0,189  Sodium/bile acid cotransporter inhibitor
0,013  0,004  Purinergic P2Y2 agonist
0,084  0,075  Protein kinase C mu inhibitor
0,082  0,074  Aminoacyl-tRNA synthetase inhibitor
0,048  0,041  Ornithine carbamoyltransferase inhibitor
0,077  0,070  Antiviral (RSV)
0,039  0,034  Hypogonadism treatment
0,015  0,010  Purinergic P2 agonist
0,015  0,010  Purinergic receptor agonist
0,085  0,079  Creatine kinase inhibitor
0,138  0,134  Antimitotic
0,050  0,046  Alcohol oxidase inhibitor
0,083  0,079  Restless leg syndrome treatment
0,054  0,051  Antidote, heavy metal
0,012  0,010  Purinergic P2Y agonist
0,024  0,023  Hypoxanthine phosphoribosyltransferase inhibitor
0,017  0,017  Inosine monophosphate dehydrogenase 1 inhibitor
0,019  0,018  Corticosteroid-like
0,012  0,011  Antibiotic Macrolide-like
0,014  0,014  Purinergic P2Y1 agonist
0,060  0,060  Carbonic anhydrase VA inhibitor

